VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Amots who wrote (20474)	4/15/1999 1:33:00 PM
From: VLAD	Read Replies (1) of 23519

Amots, Don't be so foolish as to sell a single share below 5. The market makers who are still sitting short this stock wont wanna be short on the morning of Thursday April 22, 1999. The way I see it they have "fallen and they can't get up" now. It will be funny to see all the bs spin regarding the fact that Q1 1999 product sales won't be that great but we already all know why and that at least on the international front that will all be changing in May as the third largest pharmaceutical company in the world sets to launch MUSE across Europe. Let's focus on what will be important come next Wed: 1)Earnings: how does the balance sheets looking. Is our new CFO still doing a great job with his conservative fiscal policy? Earnings estimates are at 1 cent per share. Let's see what the net profits are for Q1 1999. 2)Forward looking statements: what kind of visibility can Vivus give us regarding international product sales looking out into the rest of 1999? Anything on Japan? What about that long awaited domestic partner? Most think it will indeed be Astra/Zeneca since they do have faith in the product and they already have a close working relationship with Vivus. 3)R&D: Currently 3 very important things going on--1)Alibra finishing up phase III clinical trials. 2)Dr. Christ's research. Can his research be applied to let's say injecting the same or a similar molecule into the feet of diabetics so as to improve circulation and prevent amputation (if so this could be some very hot and heavy stuff)? 3)Female SD cream. IMO if Vivus can negotiate swiftly with the likes of AstraZeneca and get some of their management and $ muscle behind this product we can see something FDA approved next year. Sales of this type of product IMO can potentially make Vivus a $60.00+ stock in 2000. We may even hear something new about another product for let's say premature ejaculation, incontinence or prostate cancer etc... Don't forget we have 6 million shares shorted that MUST be bought back on the open market sooner or later. April 21st should give us a better idea of just how soon sooner really is. GO VIVUS!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next